The search for useful proteins: Berkeley startup aims to turn generative AI into a gene-fixing tool
Business Journals,
AI-powered Profluent Bio released the world's first open-source, AI-generated gene editor, the Berkeley company said Monday, an…
AI-powered Profluent Bio released the world's first open-source, AI-generated gene editor, the Berkeley company said Monday, an…
A small startup in Berkeley, CA, wants to help create the next wave of custom enzymes for gene editing systems with the help of…
In the early 1990s, protein biologists invested in solving a challenge that had riddled them for decades.
Boehringer Ingelheim is the latest drugmaker turning to generative AI for help in making medicines.